- Home
- MLTX vs LU Comparison
MLTX vs LU Comparison
Compare MLTX & LU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MLTX | LU |
|---|---|---|
| Founded | 2021 | 2005 |
| Country | Switzerland | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MLTX | LU |
|---|---|---|
| Price | $19.93 | $1.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 1 |
| Target Price | ★ $27.50 | $2.00 |
| AVG Volume (30 Days) | ★ 1.4M | 1.3M |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $22.52 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.95 | $1.20 |
| 52 Week High | $62.75 | $4.57 |
Technical Indicators
Market Signals| Indicator | MLTX | LU |
|---|---|---|
| Relative Strength Index (RSI) | 55.88 | 44.26 |
| Support Level | $15.54 | $1.29 |
| Resistance Level | $21.00 | $2.77 |
| Average True Range (ATR) | 1.06 | 0.07 |
| MACD | -0.11 | 0.03 |
| Stochastic Oscillator | 27.74 | 67.35 |
Price Performance
Historical ComparisonAbout MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
About LU Lufax Holding Ltd each representing two (2)
Lufax Holding Ltd is an investment holding company, together with its consolidated subsidiaries, engaged in core retail credit and enablement business to both borrowers and institutions in the People's Republic of China. The group's segments are Lending-related business, which provides Retail credit and enablement, consumer finance loans, and Digital banking business, including Retail banking and SME banking.